ARTICLE AUTHORS
ARTICLE INFO

Paratesticular Liposarcoma; a Case Report

AUTHORS

Shapour Omidvari 1 , Seyyed Hasan Hamedi 1 , Leila Moaddab-Shoar 1 , Hamid Nasrolahi 1 , * , Yahya Daneshbod 2 , Mohammad Amin Mosleh-Shirazi 1 , Mansour Ansrai 1 , Mohammad Mohammadianpanah 3 , Niloofar Ahmadloo 1 , Ahmad Mosalaei 4

1 Dept. of Radiation Oncology, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

2 Daneshbod Pathology Lab, Shiraz, Iran

3 Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

4 Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran

How to Cite: Omidvari S, Hamedi S H, Moaddab-Shoar L, Nasrolahi H , Daneshbod Y, et al. Paratesticular Liposarcoma; a Case Report, Int J Cancer Manag. 2014 ; 7(4):e80564.

ARTICLE INFORMATION

International Journal of Cancer Management: 7 (4); e80564
Published Online: December 31, 2014
Article Type: Case Report
Received: April 04, 2014
Accepted: May 29, 2014
READ FULL TEXT

Abstract

Paratesticular sarcomas have happened rarely. Due to the infrequency of this malignant disease and its diverse histopathologic subtypes, no standard treatment would be available. Multiple treatments have reported in literature with different results. We have reported a 55 years old man with a 30 years history of paratesticular mass. After multiple operations, radical orchiectomy has revealed liposarcoma. The patient has been receiving 50 Gy radiation to the scrotum and inguinal area. After 18 months follow up, the patient was well and disease free. He has shown good response to surgery and radiotherapy, so we have reported the disease and its clinical course.

Fulltext

Full text is available in PDF.
 

© 2014, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
COMMENTS

LEAVE A COMMENT HERE: